Jim Faulkner: Why unaffordable therapy success is worse than failure...
Update: 2024-01-29
Description
In this episode of Ori Spotlight Podcast, we welcome Jim Faulkner, PhD, Independent Consultant at JDB BioConsulting and former SVP of Product Delivery at Autolus.
Jim brings a wealth of experience from his remarkable career in biopharmaceutical development and his journey in the industry is marked by significant contributions, particularly in pioneering cell therapy at GSK. The episode offers a deep dive into the evolving challenges in CGT manufacturing – centering on the critical challenges of scalability and commercial viability in CGTs – and sheds light on the unique demands and opportunities in the sector.
Learn more about Jim: https://www.linkedin.com/in/drjimfaulkner/
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
